HRT Financial’s Biocept, Inc. BIOC Stock Holding History

HRT Financial’s Portfolio BIOC Stock Details BIOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,844	Closed	-$18K	–	3635
2023 Q1	$18K	Buy	+1,844	New	+$26.7K	﹤0.01%	2196
2020 Q2	–	Sell	-107	Closed	-$8K	–	1829
2020 Q1	$8K	Buy	+107	New	+$10.9K	﹤0.01%	700

Other funds holding BIOC

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

HRT Financial's BIOC Position: Q2 2023 in Review

HRT Financial sold out of Biocept, Inc. (BIOC) in Q2 2023, closing a stake of 1,844 shares — an estimated $18K sold.

HRT Financial first reported a position in BIOC in Q1 2020 and held it in 2 quarters. The position peaked at $18K in Q1 2023. 11 funds tracked by Wall St. Rank hold BIOC as of Q2 2023.

HRT Financial reported no remaining Biocept, Inc. position as of Q2 2023 after selling out during the quarter.
HRT Financial sold 1,844 Biocept, Inc. shares in Q2 2023, an estimated $18K.
HRT Financial first reported a position in Biocept, Inc. in Q1 2020 and held it in 2 quarters.
HRT Financial's Biocept, Inc. position peaked at $18K in Q1 2023.
11 funds tracked by Wall St. Rank held Biocept, Inc. as of Q2 2023.

Based on HRT Financial's 13F filing for Q2 2023, filed 11 Aug 2023.